ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
17 announcements with these filters
Star Imaging and Path Lab Limited has scheduled its 22nd Annual General Meeting for September 29, 2026. The meeting will be conducted via video conferencing.
Star Imaging and Path Lab Limited has released its Annual Report for FY 2025-26. The 22nd AGM is scheduled for September 29, 2026, via video conferencing.
The company announced the outcome of its board meeting, including approval of the draft notice for the 22nd AGM and various audit and appointment matters.
Star Imaging and Path Lab Ltd submitted its Monitoring Agency Report for the quarter ended June 30, 2026, regarding IPO proceeds utilization. The report confirms nil deviation.
Star Imaging upgraded its Tilak Nagar centre with North India's first 1184-slice CT scanner. This enhances diagnostic capabilities and strengthens the company's healthcare infrastructure.
Star Imaging reported FY26 revenue of ₹88.5cr (up 6%) and PAT of ₹19.3cr (up 21%). Management focuses on B2C expansion and becoming debt-free.
Star Imaging reported steady FY26 growth despite regulatory delays in new centers. Management shifted focus to FY27, banking on a capacity ramp-up and improved government receivables to drive momentum.
Star Imaging reports FY26 revenue of ₹88.5cr (+6% YoY) and PAT of ₹19.3cr (+21% YoY). Strategy focuses on PPP models and expanding B2B networks.
Star Imaging and Path Lab Ltd reported revenue from operations of ₹43.3 Cr (+5.9% YoY) and net profit of ₹9.2 Cr (-5.2% YoY) for H2 FY26.
Star Imaging And Path Lab reported standalone annual revenue of ₹88.62 Crore. The Board approved audited financial results with an unmodified auditor opinion.
Star Imaging and Path Lab appointed NeoAtlas Capital Advisory LLP as its Investor Relations Advisor. This move aims to strengthen investor engagement and capital market communications.
Star Imaging and Path Lab Limited reported utilization of its ₹55.66 Crore IPO proceeds. The monitoring agency confirmed no deviations from the stated objects.
Star Imaging and Path Lab Limited confirmed it is not a Large Corporate. Consequently, the company is exempt from debt-raising disclosure requirements for fiscal 2026-27.
Star Imaging and Path Lab Limited confirmed it is not identified as a 'Large Corporate' as of March 31, 2026, under SEBI debt issuance norms. Consequently, the requirement for mandatory borrowing through debt securities does not apply for FY 2026-27. The company reported outstanding borrowings of ₹7.93 Crore as of the reporting date.
Star Imaging and Path Lab Limited informed the exchange that the requirement to submit an Annual Secretarial Compliance Report under Regulation 24A is not applicable to them. This exemption applies as the company is listed on the BSE SME Exchange and falls under Regulation 15(2)(b) of the SEBI (LODR) Regulations.
Star Imaging and Path Lab Limited clarified to BSE that recent share price movements are market-driven and not due to undisclosed material information. The company confirmed compliance with all SEBI disclosure regulations.
Star Imaging and Path Lab Limited is expanding its network by setting up a new diagnostic centre in Dwarka, New Delhi. The project involves a ₹14 Crore capital expenditure and is expected to commence operations by August 1, 2026. The facility is secured via a 9-year lease agreement as part of the company's regional expansion strategy.